· Strides to invest ₹1,350 million over the next 24 months · Strides to have ~54% ownership in the SteriScience injectable platform Mumbai, September 14, 2020 (GPN): – Strides Pharma Science Limited (‘Strides’ or ‘Company’), a global pharmaceutical…
MUMBAI, 21 AUGUST, 2020 (GPN) – Strides Pharma Science Limited (Strides) today announced that its step-down wholly owned subsidiary, Strides Pharma Global Pte. Limited, Singapore, has received approval for Ursodiol Tablets USP, 250 mg and 500 mgfrom…
MUMBAI, AUGUST 19, 2020 (GPN) – Strides Pharma Science Limited (Strides) today announced the successful completion of the inspection carried out by the UK Medicines and Healthcare products Regulatory Agency (UK MHRA) at its Puducherry facility…
To be marketed by Strides Pharma Inc. in the US market MUMBAI, JULY 09, 2020 (GPN)- Strides Pharma Science Limited (Strides) today announced that its step-down wholly owned subsidiary, Strides Pharma Global Pte. Limited, Singapore, has…
Product approval from flagship facility in Bangalore To be marketed by Strides Pharma Inc. in the US market MUMBAI, JUNE 02, 2020 (GPN)- Strides Pharma Science Limited (Strides) today announced that its step-down wholly owned…
